SynthesisDiabetic medicine : a journal of the British Diabetic Association2025
Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta-analysis.
Synthesis in Diabetic medicine : a journal of the British Diabetic Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta-analysis.Diabetic medicine : a journal of the British Diabetic Association · 2025Pooled it
- Ten tips on how to prevent falls in dialysis patients.Clinical kidney journal · 2026Review
- Band keratopathy and conjunctival calcification in end-stage kidney disease: epidemiology, pathophysiology and clinical management.Clinical kidney journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimPeople with diabetes receiving haemodialysis are at increased risk of diabetic retinopathy (DR) and other ocular complications. Despite this heightened vulnerability, evidence on the prevalence of such conditions in this population is limited. This review aimed to synthesise the existing literature on the prevalence of DR and other ocular conditions, and to evaluate screening rates in people with diabetes undergoing haemodialysis.
methodsA systematic search of MEDLINE, EMBASE and CINAHL databases was conducted to identify studies reporting on the prevalence of DR, diabetic maculopathy and other ocular conditions in people with diabetes on haemodialysis. Eight articles meeting inclusion criteria were included. Pooled prevalence estimates and 95% confidence intervals (CIs) were calculated using random-effects models.
resultsThe pooled prevalence of DR was 49.1% (95% CI: 23.1-75.4), while diabetic maculopathy prevalence was 32.5% (95% CI: 10.9-59.1). Other ocular complications reported included cataracts (53.4%), conjunctival calcification (63%) and corneal calcification (45.3%). Notably, 54.3% (95% CI: 35.4-72.6) of individuals on haemodialysis had not undergone eye screening in over two years.
conclusionThis review reveals a high prevalence of DR and other ocular complications in people with diabetes undergoing haemodialysis, alongside significant under-screening. Future research should focus on developing and accessing targeted interventions to improve screening uptake in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.